Next Article in Journal
Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease
Next Article in Special Issue
An Editorial on the Special Issue ‘Hsp90 Structure, Mechanism and Disease’
Previous Article in Journal
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Previous Article in Special Issue
Cytosolic Hsp90 Isoform-Specific Functions and Clinical Significance
 
 
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
Review

Article Versions Notes

Biomolecules 2023, 13(2), 251; https://doi.org/10.3390/biom13020251
Action Date Notes Link
article html file updated 29 December 2025 19:52 CET Update https://www.mdpi.com/2218-273X/13/2/251/html
article html file updated 11 September 2025 01:26 CEST Update -
article html file updated 4 September 2025 03:06 CEST Update -
article html file updated 8 March 2023 03:18 CET Update -
article html file updated 1 March 2023 11:34 CET Update -
article html file updated 29 January 2023 09:27 CET Original file -
article pdf uploaded. 29 January 2023 09:25 CET Version of Record https://www.mdpi.com/2218-273X/13/2/251/pdf
article xml uploaded. 29 January 2023 09:25 CET Update https://www.mdpi.com/2218-273X/13/2/251/xml
article xml file uploaded 29 January 2023 09:25 CET Original file -
Back to TopTop